These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22966852)

  • 1. Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy.
    Kandala J; Upadhyay GA; Altman RK; Bose A; Heist EK; Mela T; Singh JP
    J Cardiovasc Electrophysiol; 2013 Feb; 24(2):182-7. PubMed ID: 22966852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy.
    Kandala J; Upadhyay GA; Altman RK; Parks KA; Orencole M; Mela T; Kevin Heist E; Singh JP
    Eur Heart J; 2013 Aug; 34(29):2252-62. PubMed ID: 23571836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of right ventricular to left ventricular interlead sensed electrical delay in cardiac resynchronization therapy.
    Kristiansen HM; Hovstad T; Vollan G; Keilegavlen H; Faerestrand S
    Europace; 2012 Jul; 14(7):986-93. PubMed ID: 22308084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of two surgical alternatives for cardiac resynchronization therapy: trans-apical versus epicardial left ventricular pacing.
    Mihalcz A; Kassai I; Kardos A; Foldesi C; Theuns D; Szili-Torok T
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):124-30. PubMed ID: 22017475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy.
    Friedman DJ; Upadhyay GA; Altman RK; Orencole M; Barrett CD; Mela T; Kevin Heist E; Singh JP
    Heart Rhythm; 2013 May; 10(5):668-75. PubMed ID: 23274368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The left ventricular lead electrical delay predicts response to cardiac resynchronisation therapy.
    Zhang H; Dai Z; Xiao P; Pan C; Zhang J; Hu Z; Chen S
    Heart Lung Circ; 2014 Oct; 23(10):936-42. PubMed ID: 24996391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlead distance and left ventricular lead electrical delay predict reverse remodeling during cardiac resynchronization therapy.
    Merchant FM; Heist EK; Nandigam KV; Mulligan LJ; Blendea D; Riedl L; McCarty D; Orencole M; Picard MH; Ruskin JN; Singh JP
    Pacing Clin Electrophysiol; 2010 May; 33(5):575-82. PubMed ID: 20070543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraordinarily favorable left ventricular reverse remodeling through long-term cardiac resynchronization: super-response to cardiac resynchronization.
    Çelebi Ö; Knaus T; Blaschke F; Habedank D; Döhner W; Nitardy A; Stockburger M
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):870-6. PubMed ID: 22553930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of electroanatomical mapping during transseptal endocardial left ventricular lead implantation.
    Kutyifa V; Merkely B; Szilágyi S; Zima E; Róka A; Király A; Osztheimer I; Molnár L; Széplaki G; Gellér L
    Europace; 2012 Apr; 14(4):599-604. PubMed ID: 22194467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular electrical activation during right ventricular pacing in heart failure patients with LBBB: visualization by electrocardiographic imaging and implications for cardiac resynchronization therapy.
    Varma N
    J Electrocardiol; 2015; 48(1):53-61. PubMed ID: 25301520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and morbidity in cardiac resynchronization patients: impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome.
    Jastrzebski M; Wilinski J; Fijorek K; Sondej T; Czarnecka D
    Europace; 2013 Feb; 15(2):258-65. PubMed ID: 23047489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of a pacing guidewire to facilitate left ventricular lead implantation in cardiac resynchronization therapy.
    de Cock CC; Res JC; Hendriks ML; Allaart CP
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):446-9. PubMed ID: 19335852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.
    Singh JP; Klein HU; Huang DT; Reek S; Kuniss M; Quesada A; Barsheshet A; Cannom D; Goldenberg I; McNitt S; Daubert JP; Zareba W; Moss AJ
    Circulation; 2011 Mar; 123(11):1159-66. PubMed ID: 21382893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing.
    Miranda RI; Nault M; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):370-4. PubMed ID: 22049976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.